CLINICAL_TRIALS
trial_result
· 2013-07-11
Clinical Trial Update: Cyclic Oral Methylprednisolone Trial in Multiple Sclerosis [Phase 2]
Summary
Phase 2 trial of cyclic oral methylprednisolone for progressive multiple sclerosis has completed enrollment/status.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Rigshospitalet, Denmark | Conditions: Progressive Multiple Sclerosis | Phase 2 | Status: COMPLETED